Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2014-03-07 Major Shareholding Noti…
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 1% confidence The document details a change in the holding structure of a major shareholder (Skålguldet 328 Kommanditbolag changing its name to HealthCap Orx Holdings Kommanditbolag) in Orexo AB. It explicitly states the number of shares held before and after the transaction, the resulting percentage (16.8%), and notes that the change is due to internal transfers between HealthCap-controlled entities. This structure—reporting changes in significant share ownership thresholds—directly corresponds to the definition of a Major Shareholding Notification. The code for this is MRQ.
2014-03-07 English
Number of shares and votes in Orexo
Share Issue/Capital Change Classification · 1% confidence The document is a short press release dated January 31, 2014, announcing a change in the total number of shares and votes in Orexo AB due to the exercise of warrants. This directly relates to a change in the company's capital structure or share count. The most specific category for changes in share count or capital structure is 'Share Issue/Capital Change' (SHA). While it could potentially be a general 'Regulatory Filing' (RNS), SHA is a better fit as it specifically addresses the change in the number of shares outstanding.
2014-01-31 English
Antal aktier och röster i Orexo
Share Issue/Capital Change Classification · 1% confidence The document is a short press release (1681 characters) titled "Antal aktier och röster i Orexo" (Number of shares and votes in Orexo). It explicitly states that the number of shares and votes has changed due to the exercise of stock options, and it provides the total number of shares as of the last trading day of the month (January 31, 2014). This type of announcement, detailing changes in the total share count or voting rights, aligns best with categories related to capital structure changes or major shareholding notifications. Since it is a direct announcement of a change in the total number of shares/votes, it fits the description of 'Share Issue/Capital Change' (SHA) or potentially 'Major Shareholding Notification' (MRQ) if it implies a threshold crossing, but the core information is the total share count change. Given the context of options being exercised leading to a new total share count, SHA is the most precise fit among the options for capital structure changes. It is not an ER, IR, or 10-K as it lacks detailed financial statements. It is a direct announcement, not a report publication announcement (RPA).
2014-01-31 Swedish
Earnings Release 2013
Earnings Release Classification · 1% confidence The document contains detailed financial highlights for the full year 2013 and the fourth quarter (Oct-Dec), including revenue, net income, EPS, and cash flow, presented in a structured format with comparative figures from 2012. It also includes a CEO commentary and operational review focusing on product launches (Zubsolv, Abstral) and commercial strategy. The presence of comprehensive annual financial data, management discussion, and a summary table strongly indicates this is an Annual Report or a comprehensive period report. Since it covers the full fiscal year (Jan-Dec 2013) and contains detailed financial statements/summaries, it aligns best with the definition of an Annual Report (10-K), although the text is in Swedish and might be the local equivalent or a preliminary version thereof. Given the depth of the annual review and financial tables, 10-K is the most appropriate classification among the options, rather than a shorter Interim Report (IR) or just an Earnings Release (ER). The length (over 62,000 characters) confirms it is a substantial report, not just an announcement (RPA/RNS). FY 2013
2014-01-30 Swedish
Earnings Release 2013
Earnings Release Classification · 1% confidence The document provides a detailed summary of financial performance for the full year 2013, including key metrics like Net revenues, Earnings after tax, and Earnings per share, comparing them to 2012. It includes a CEO's comments section, operational updates on key products (Zubsolv and Abstral), and a financial table covering both quarterly (Oct-Dec) and full-year (Jan-Dec) results. The presence of comprehensive financial data, management discussion, and annual comparison strongly indicates this is an Annual Report, which corresponds to the 10-K filing type in the US context, or a similar comprehensive annual review document. Given the structure and depth, it is classified as 10-K, as it covers the full fiscal year performance. FY 2013
2014-01-30 English
Orexo justerar förväntat rörelseresultat för fjärde kvartalet 2013
Earnings Release Classification · 1% confidence The document is a press release dated December 20, 2013, titled "Orexo justerar förväntat rörelseresultat för fjärde kvartalet 2013" (Orexo adjusts expected operating result for the fourth quarter of 2013). It announces a change in the expected EBIT for Q4 2013, revising a previously positive outlook to a negative result of approximately -30 million SEK due to conservative revenue recognition policies related to Zubsolv sales. This is a preliminary announcement of financial performance expectations, not the full comprehensive report (10-K or IR) nor the final, formal earnings release (ER) which usually contains detailed statements and finalized figures. Given that it is an early announcement adjusting expectations for a specific period, it most closely aligns with an Earnings Release (ER) which covers periodical financial results (even if preliminary or adjusted). It is too specific for a general Regulatory Filing (RNS) and does not fit the other categories. Q4 2013
2013-12-20 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.